CHRNA9 Antikörper (N-Term)
Kurzübersicht für CHRNA9 Antikörper (N-Term) (ABIN7304212)
Target
Alle CHRNA9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Recognizes endogenous levels of CHRNA9 protein.
-
Produktmerkmale
- Rabbit polyclonal antibody to CHRNA9
-
Aufreinigung
- The antibody was purified by immunogen affinity chromatography.
-
Immunogen
- KLH-conjugated synthetic peptide encompassing a sequence within the N-term region of human CHRNA9.
-
-
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (AA 8-42), (N-Term) antibody
CHRNA9 Reaktivität: Human WB, FACS Wirt: Kaninchen Polyclonal RB46802 unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (AA 26-240) antibodyCHRNA9 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (AA 139-221) antibodyCHRNA9 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 8E4 unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (AA 8-42) antibodyCHRNA9 Reaktivität: Human WB, IHC, FACS, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (N-Term) antibodyCHRNA9 Reaktivität: Human, Hund, Rind (Kuh), Pferd, Kaninchen, Meerschweinchen, Zebrafisch (Danio rerio), Schwein, Fledermaus, Affe WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (N-Term) antibodyCHRNA9 Reaktivität: Human, Maus, Ratte, Hund, Huhn WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (N-Term) antibodyCHRNA9 Reaktivität: Maus, Hund, Rind (Kuh), Pferd, Kaninchen, Meerschweinchen, Zebrafisch (Danio rerio) WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (AA 436-450), (Cytoplasmic) antibodyCHRNA9 Reaktivität: Ratte WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) antibodyCHRNA9 Reaktivität: Human, Maus, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- WB (1:500 - 1:1000)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- CHRNA9 (Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9))
-
Andere Bezeichnung
- CHRNA9
-
Hintergrund
- NACHRA9, Neuronal acetylcholine receptor subunit alpha-9, Nicotinic acetylcholine receptor subunit alpha-9, NACHR alpha-9
-
Gen-ID
- 55584
-
UniProt
- Q9UGM1
-
Pathways
- Sensory Perception of Sound
Target
-
